Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GBA modulators(Beta-glucocerebrosidase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22IN3O4 |
InChIKeyHFVDMJQQAKLUSN-UHFFFAOYSA-N |
CAS Registry1462267-07-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gaucher Disease | Preclinical | US | 13 Jul 2016 | |
Parkinson Disease | Preclinical | US | 13 Jul 2016 |